Blusztajn_1995_Clin.Exp.Pharmacol.Physiol_22_368

Reference

Title : Use of differentiated cholinergic and second messenger endpoints to evaluate cholinesterase inhibitors - Blusztajn_1995_Clin.Exp.Pharmacol.Physiol_22_368
Author(s) : Blusztajn JK , Davis RO
Ref : Clinical & Experimental Pharmacology & Physiology , 22 :368 , 1995
Abstract : Blusztajn_1995_Clin.Exp.Pharmacol.Physiol_22_368
ESTHER : Blusztajn_1995_Clin.Exp.Pharmacol.Physiol_22_368
PubMedSearch : Blusztajn_1995_Clin.Exp.Pharmacol.Physiol_22_368
PubMedID: 7554433

Related information

Citations formats

Blusztajn JK, Davis RO (1995)
Use of differentiated cholinergic and second messenger endpoints to evaluate cholinesterase inhibitors
Clinical & Experimental Pharmacology & Physiology 22 :368

Blusztajn JK, Davis RO (1995)
Clinical & Experimental Pharmacology & Physiology 22 :368